Showing results (1641-1650 of 15,705) with videos related to

Sort By:
Pageof 1,571
Oncology Letters|June 29, 2022
Principal component analysis of early immune cell dynamics during pembrolizumab treatment of advanced urothelial carcinomaTaro Teshima, Yukari Kobayashi, Taketo Kawai, et al.
Oncology Letters|June 29, 2022
Absolute lymphocyte count and C-reactive protein-albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapyHiroyuki Inoue, Atsushi Shiozaki, Hitoshi Fujiwara, et al.
Oncology Letters|June 29, 2022
miR-4735-3p inhibits cell migration and invasion of gastric cancer by downregulating NEDD9Yanchun Ma
Oncology Letters|June 4, 2021
MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and in vitro experimentsMinde Li, Lin Zhou, Shaoyang Li, et al.
Oncology Letters|June 4, 2021
Long non-coding RNA CASC9/microRNA-590-3p axis participates in lutein-mediated suppression of breast cancer cell proliferationYuxia Zhang, Jingzhi Chang, Weiwei Jiang, et al.
Oncology Letters|June 7, 2021
Cytochrome P450: Implications for human breast cancerBin Luo, Dandan Yan, Honglin Yan, et al.
Oncology Letters|June 7, 2021
Formosanin C promotes the curative efficacy of ultrasound-guided radiofrequency ablation in a mouse model of breast cancerZhe Chen, Jing Li, Qianqian Cui, et al.
Oncology Letters|June 7, 2021
MicroRNA expression profiling involved in doxorubicin-induced cardiotoxicity using high-throughput deep-sequencing analysisYing Chen, Yingjie Xu, Zhoufeng Deng, et al.
Oncology Letters|June 7, 2021
Clinical value of color Doppler ultrasound combined with serum tumor markers for the diagnosis of medullary thyroid carcinomaXue Yang, Jinjuan Xu, Jilan Sun, et al.
Oncology Letters|June 3, 2021
miR-590-5p targets RMND5A and promotes migration in pancreatic adenocarcinoma cell linesSixing Chen, Yu Chen, Yao Wen, et al.
Pageof 1,571